Epigenetics and ADHD: Reflections on Current Knowledge, Research Priorities and Translational Potential
Charlotte A M Cecil1,2,3, Joel T Nigg4
1Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia, Rotterdam, The Netherlands. c.cecil@erasmusmc.nl.
Insights
Epigenetics, particularly DNA methylation, offers a promising molecular approach to understanding attention-deficit/hyperactivity disorder (ADHD). While still in early stages, this research may lead to better ADHD prediction and personalized treatments.
Area of Science:
- Neurodevelopmental Disorders
- Molecular Psychiatry
- Epigenetics
Background:
- Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder with complex genetic and environmental influences.
- Understanding the molecular interplay between these factors is crucial for improving ADHD prediction, prevention, and treatment strategies.
- Epigenetic mechanisms, such as DNA methylation, are increasingly recognized for their role in regulating gene expression and influencing disease risk.
Purpose of the Study:
- To review the current state of knowledge regarding epigenetics, specifically DNA methylation, in the context of ADHD research.
- To discuss the challenges and future directions for utilizing epigenetic insights in ADHD clinical practice and personalized medicine.
- To highlight the potential of DNA methylation as a biomarker and mechanistic target for ADHD.
Main Methods:
- This is a Current Opinion review, synthesizing existing research on epigenetics and ADHD.
- The discussion focuses on DNA methylation as a key epigenetic mechanism.
- It examines current knowledge, challenges, and future prospects for translational applications.
Main Results:
- The field of epigenetics in ADHD is promising but remains in its early stages of development.
- Transformative translational applications of epigenetic findings for ADHD are currently a distant goal.
- Methodological advancements and collaborative research are accelerating progress in this area.
Conclusions:
- Epigenetics, particularly DNA methylation, holds significant potential for advancing ADHD research and clinical practice.
- Further research is needed to overcome current challenges and realize the full potential of methylation-based applications for personalized ADHD medicine.
- The integration of high-quality longitudinal data and collaborative science will be key to future breakthroughs in ADHD prediction, management, and treatment.
Abstract:
Attention-deficit/hyperactivity disorder (ADHD) is a common and debilitating neurodevelopmental disorder influenced by both genetic and environmental factors, typically identified in the school-age years but hypothesized to have developmental origins beginning in utero. To improve current strategies for prediction, prevention and treatment, a central challenge is to delineate how, at a molecular level, genetic and environmental influences jointly shape ADHD risk, phenotypic presentation, and developmental course. Epigenetic processes that regulate gene expression, such as DNA methylation, have emerged as a promising molecular system in the search for both biomarkers and mechanisms to address this challenge. In this Current Opinion, we discuss the relevance of epigenetics (specifically DNA methylation) for ADHD research and clinical practice, starting with the current state of knowledge, what challenges we have yet to overcome, and what the future may hold in terms of methylation-based applications for personalized medicine in ADHD. We conclude that the field of epigenetics and ADHD is promising but is still in its infancy, and the potential for transformative translational applications remains a distant goal. Nevertheless, rapid methodological advances, together with the rise of collaborative science and increased availability of high-quality, longitudinal data make this a thriving research area that in future may contribute to the development of new tools for improved prediction, management, and treatment of ADHD.
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
01:28Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
01:23Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
01:46Epigenetic Regulation
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
01:30Introduction to Biological Bases of Psychology
The nervous system, the cornerstone of...